Overcoming the Moderate Efficacy Conundrum in PDE4 Inhibition through Hidradenitis Suppurativa

Time: 11:30 am
day: Day 2 AM - Track B


  • Outlining PDE4i mode of action and the therapeutic potential to treat across numerous indications with serious unmet need
  • Identifying subtypes to target B & D specificity in candidate compound
  • Championing an oral delivery method with a good safety profile drug candidate